Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: a retrospective review of 1114 patients

References

• Barton M, O'Brien P. Hodgkin's disease presenting below the diaphragm. Hodgkin's disease, P M Mauch, J O Armitage, V Diehl, R T Hoppe, L M Weiss. Lippincott Williams and Wilkins, Philadelphia, PA 1999; 727–737
   Google Scholar
• Leibenhaut M H, Hoppe R T, Varghese A, Rosenberg S A. Subdiaphragmatic Hodgkin' disease: laparotomy and treatment results in 49 patients. Journal of Clinical Oncology 1987; 5: 1050–1055
   PubMed Web of Science ®Google Scholar
• Mauch P, Greenberg H, Lewin A, Cassady J R, Weichselbaum R, Hellman S. Prognostic factors in patients with subdiaphragmatic Hodgkin's disease. Hematology & Oncology 1983; 1: 205–214
   PubMedGoogle Scholar
• Mauch P, Tarbell N, Weinstein H, Silver B, Gottman T, Osteen R, et al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. Journal of Clinical Oncology 1988; 6: 1576–1583
   PubMed Web of Science ®Google Scholar
• Peters V M. A study of survival in Hodgkin's disease treated radiologically. American Journal of Roentgenology 1950; 63: 299–311
   Web of Science ®Google Scholar
• Krikorian J G, Portlock C S, Rosenberg S A, Kaplan H S. Hodgkin's disease, stages I and II occurring below the diaphragm. Cancer 1979; 43: 1866–1871
   PubMed Web of Science ®Google Scholar
• Barrett A, Gregor A, McElwain T J, Peckham M J. Infradiaphragmatic presentation of Hodgkin's disease. Clinical Radiology 1981; 32: 221–224
   PubMed Web of Science ®Google Scholar
• Barton M, Boyages J, Crennan E, Davis S, Fischer R J, Hook C. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience. Radiotherapy & Oncology 1996; 39: 1–7
   PubMed Web of Science ®Google Scholar
• Cionini L, Magrini S, Mungai V, Biti G P, Ponticelli P. Stage I and II Hodgkin's disease presenting in infradiaphragmatic nodes. Tumori 1982; 68: 519–525
   PubMed Web of Science ®Google Scholar
• Dorreen M S, Wrigley P F, Laidlow J M. The management of stage II supradiaphragmatic Hodgkin' disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years. Cancer 1984; 54: 2882–2888
   PubMed Web of Science ®Google Scholar
• Enrici R M, Osti M F, Anselmo A P, Banelli E, Cartoni C, Sbarbati S, et al. Hodgkin's disease stage I and II with exclusive subdiaphragmatic presentation. The experience of the Department of Radiation Oncology and Hematology, University ‘La Sapienza’ of Rome. Tumori 1996; 82: 48–52
   PubMed Web of Science ®Google Scholar
• Henry-Amar M, Aeppli D M, Abderson J, Ashley S, Bonicho F, Cox R S, . Workshop statistical report. Treatment strategy in Hodgkin's disease: Collque INSERM, R Somers, M Henry-Amar, J K Meerwaldt, et al. Paris/France/John Libbey Eurotext Ltd, London 1990; vol. 196: 217
   Google Scholar
• Krikorian J G, Portlock C S, Mauch P M. Hodgkin's disease presenting below the diaphragm: a review. Journal of Clinical Oncology 1986; 4: 1551–1562
   PubMed Web of Science ®Google Scholar
• Mai D H-W, Peschel R E, Portlock C, Knowlton A, Farber L. Stage I and II sub diaphragmatic Hodgkin's disease. Cancer 1991; 68: 1476–1481
   PubMed Web of Science ®Google Scholar
• Mason M D, Law M, Ashley S, Nichols J, Brada M, Peckham M J, Horwich A. Infradiaphragmatic Hodgkin's disease. European Journal of Cancer 1992; 28A: 1851–1852
   PubMed Web of Science ®Google Scholar
• Roos D E, O'Brien P C, Wright J, Wilson K. Treatment of subdiaphragmatic Hodgkin's disease: is radiotherapy alone appropriate only for inguino-femoral presentations?. International Journal of Radiation Oncology, Biology & Physics 1994; 28: 683–691
   PubMed Web of Science ®Google Scholar
• Rappaport H, Berard C W, Butler J J, Dorfman R F, Lukes R J, Thomas L B. Report of the committee on histopathological criteria contributing to staging of Hodgkin's disease. Cancer Research 1971; 31: 1864–1865
   PubMed Web of Science ®Google Scholar
• Kälkner K M, Enblad G, Gustavsson A, Starkhammer H, Branehog I, Lenner P, Glimelius B. Infradiaphragmatic Hodgkin's disease: the Swedish National Care Programme experience. The Swedish Lymphoma Study Group. European Journal of Haematology 1997; 59: 31–37
   PubMed Web of Science ®Google Scholar
• Duehmke E, Franklin J, Pfreundschuh M, Sehlen S, Willich N, Ruehl U, et al. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone. Journal of Clinical Oncology 2001; 19: 2905–2914
   PubMed Web of Science ®Google Scholar
• Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, et al. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the GHSG Trial HD5. Journal of Clinical Oncology 2002; 20: 476–484
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Non-parametric estimation from incomplete observations. American Statistics Association Journal 1958; 53: 457–480
   Web of Science ®Google Scholar
• Enblad G, Glimelius B, Sundstrom C. Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based study. Annals of Oncology 1991; 2: 297–302
   PubMed Web of Science ®Google Scholar
• Epstein E. Sex as a factor in the prognosis of Hodgkin's disease. American Journal of Cancer 1939; 35: 230
   Google Scholar
• Gross R, Zach J, Schulten H K. Die Lymphogranulomatose. Diagnostisch-prognostische Hinweise anhand von 700 Fällen. Dtsch Med Wschr 1966; 91: 521, (in German)
   Google Scholar
• Heilmeyer L, Mössner G, Hunstein W. Die Lymphogranulomatose. Dtsch Med Wschr 1957; 82: 1046, (in German)
   PubMed Web of Science ®Google Scholar
• Musshoff K, Busch M, Kaminski H. Lymphogranulomatose mit Knochenbefall. Symptomatologie mit besonderer Berücksichtigung des Röntgenbildes, Therapie und Prognose. Ein Bericht über 66 Fälle (Freiburger Krankengut 1948–1961). Fortschr Geb Röntgenstr 1964; 101: 117, (in German)
   Google Scholar
• Somers R, Tubiana M, Henry-Amar M. EORTC (European Organisation for Research and Treatment of Cancer) Lymphoma Cooperative Group studies in clinical stage I–II Hodgkin's disease 1963–1987. Recent Results in Cancer Research 1989; 117: 175–181
   PubMedGoogle Scholar
• Ferrant A, Hamoir V, Binon J, Michaux J L, Sokal G. Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease. Cancer 1985; 55: 317–322
   PubMed Web of Science ®Google Scholar
• Longo D L, Duffey P L, DeVita V T, Jr, Devita V T, Jr, Wiernik P H, Hubbard S M, et al. Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP. Journal of Clinical Oncology 1991; 9: 1409–1420
   PubMed Web of Science ®Google Scholar
• Longo D L, Russo A, Duffey P L. Treatment of advanced-stage massive Hodgkin's disease: the case of combined modality treatment. Journal of Clinical Oncology 1991; 9: 227–235
   PubMed Web of Science ®Google Scholar